An analysis of the SWEDEHEART registry supports current guideline recommendations that surgical management is appropriate and ...
Late-breaking trials from the TCT and AHA meetings took over the list this month, the lone outlier being our COVID-19 ...
The lack of short-term risk with the Pfizer/BioNTech mRNA shot should “close the book” on CVD concerns, a researcher says.
Treatments are limited for surgery-ineligible patients with severe AR, but this particular TAVI system is raising hopes.
Real-world data point to durable effects on MR, but Alison Duncan says transcatheter MV replacement has a ways to go.
In a sign of the viral disease’s varied effects, distributive shock outnumbered cardiogenic and few cases were tied to acute ...
Alerts need to work or else they should be removed to avoid alert fatigue, which can cause harm to patients, say researchers.
Understanding predictors of HF hospitalization will hone patient selection and procedure timing, and may improve outcomes.
Thinking big picture, a scientific statement outlines 10 features of healthy diets and explores how environments affect ...
The phenomenon is not without precedent, with many CVD risk factors increasing following natural disasters, says one expert.
The added procedure failed to significantly reduce atrial arrhythmia recurrence in patients with persistent AF.
There was a trend toward protection, suggesting a larger study with more events might be needed to know if aspirin is helpful ...